New treatments for chronic prostatitis/chronic pelvic pain syndrome

Nature Reviews Urology

Volumn 7, Issue 3, 2010, Pages 127-135

  Strauss, Adam C ^a   Dimitrakov, Jordan D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BOTULINUM TOXIN A; CC 10004; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; FINASTERIDE; GABAPENTIN; LEVOFLOXACIN; LIDOCAINE; MEMANTINE; MEPARTRICIN; NERVE GROWTH FACTOR ANTIBODY; PENTOSAN POLYSULFATE; PLACEBO; POLLEN EXTRACT; PREDNISONE; PREGABALIN; QUERCETIN; ROFECOXIB; SILODOSIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TANEZUMAB; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; 4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ANTICHOLINERGIC SYNDROME; ANTIINFLAMMATORY ACTIVITY; CHRONIC PROSTATITIS; CLINICAL TRIAL; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; HUMAN; HYPERTENSION; HYPERTHERMIC THERAPY; MASSAGE; MICTURITION DISORDER; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; PELVIC FLOOR MUSCLE TRAINING; PELVIS PAIN SYNDROME; PERIPHERAL EDEMA; PHYSIOTHERAPY; PHYTOTHERAPY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SYMPTOM; CHRONIC DISEASE; COGNITIVE THERAPY; COMPLICATION; MALE; PELVIC PAIN; PROCEDURES; PROSTATITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; TRENDS;

AMINES; CHRONIC DISEASE; COGNITIVE THERAPY; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PELVIC PAIN; PROSTATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77949423573     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.4     Document Type: Review

References (92)

1. Nickel, J. C. in Campbell-Walsh Urology 9th edn (eds wein, A. J., Kavoussi, L. R., Novick, A. C., Partin, A. w. & Peters, C. A.) 305-329 (Saunders, Philadelphia, 2007).
2. Wenninger, K., Heiman, J. R., Rothman, I., Berghuis, J. P. & Berger, R. E. Sickness impact of chronic nonbacterial prostatitis and its correlates. J. Urol. 155, 965-968 (1996).
3. McNaughton Collins, M. et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J. Gen. Intern. Med. 16, 656-662 (2001).
4. Walz, J. et al. impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int. 100, 1307-1311 (2007).
5. Tripp, D. A., Curtis Nickel, J., Landis, J. R., Wang, Y. L. & Knauss, J. S. Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National institutes of Health Chronic Prostatitis Cohort Study. BJU Int. 94, 1279-1282 (2004).
6. Tripp, D. A., Nickel, J. C., Ross, S., Mullins, C. & Stechyson, N. Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16-19 years. BJU Int. 103, 1080-1084 (2009).
7. Krieger, J. N., Nyberg, L. Jr & Nickel, J. C. NiH consensus definition and classification of prostatitis. JAMA 282, 236-237 (1999).
8. Schaeffer, A. J. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N. Engl. J. Med. 355, 1690-1698 (2006).
9. Alexander, R. B. Treatment of chronic prostatitis. Nat. Clin. Pract. Urol. 1, 2-3 (2004).
10. Alexander, R. B. Prostatitis: clinical phenotyping of patients with pelvic pain. Nat. Rev. Urol. 6, 531-532 (2009).
11. Nickel, J. C. et al. Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 101, 59-64 (2008).
12. Pontari, M. A. et al. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int. 96, 559-565 (2005).
13. Schaeffer, A. J. NiDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis. Int. J. Antimicrob. Agents 24 (Suppl. 1), S49-S52 (2004).
14. Nickel, J. C. et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N. Engl. J. Med. 359, 2663-2673 (2008).
15. Potts, J. M. Chronic pelvic pain syndrome: a non-prostatocentric perspective. World J. Urol. 21, 54-56 (2003).
16. Potts, J. & Payne, R. E. Prostatitis: infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleve. Clin. J. Med. 74 (Suppl. 3), S63-S71 (2007).
17. Woolf, C. J. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann. Intern. Med. 140, 441-451 (2004).
18. US Department of Health and Human Services US Preventive Services Task Force Grade Definitions [online], http://www.ahrq.gov/clinic/ uspstf/grades.htm (2009).
19. Yoshimura, N. & Chancellor, M. in Campbell-Walsh Urology 9th edn (eds wein, A. J., Kavoussi, L. R., Novick, A. C., Partin, A. w. & Peters, C. A.) 1922-1972 (Saunders, Philadelphia, 2007).
20. Nickel, J. C., Downey, J., Johnston, B. & Clark, J. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J. Urol. 165, 1539-1544 (2001).
21. Alexander, R. B. et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann. Intern. Med. 141, 581-589 (2004).
22. Nickel, J. et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62, 614-617 (2003).
23. Zeng, X. et al. Clinical evaluation of celecoxib in treating type iiiA chronic prostatitis [Chinese]. Zhonghua Nan Ke Xue 10, 278-281 (2004).
24. Tomaskovic, i., Ruzic, B., Trnski, D. & Kraus, O. Chronic prostatitis/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy. Med. Hypotheses 72, 261-262 (2009).
25. Yang, M. G. et al. Corticoid combined with an antibiotic for chronic nonbacterial prostatitis [Chinese]. Zhonghua Nan Ke Xue 15, 237-240 (2009).
26. Bates, S. & Talbot, M. Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one non-responder. Sex. Transm. Infect. 76, 398-399 (2000).
27. Yun, A. J. & Doux, J. D. Opening the floodgates: benign prostatic hyperplasia may represent another disease in the compendium of ailments caused by the global sympathetic bias that emerges with aging. Med. Hypotheses 67, 392-394 (2006).
28. Anglin, I. E., Glassman, D. T. & Kyprianou, N. induction of prostate apoptosis by alpha1- adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis. 5, 88-95 (2002).
29. Dimitrakov, J. D., Kaplan, S. A., Kroenke, K., Jackson, J. L. & Freeman, M. R. Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach. Urology 67, 881-888 (2006).
30. Nickel, J. C., Downey, J., Pontari, M. A., Shoskes, D. A. & Zeitlin, S. I. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category iiiA chronic nonbacterial prostatitis). BJU Int. 93, 991-995 (2004).
31. Kaplan, S. A., volpe, M. A. & Te, A. E. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category iii prostatitis/chronic pelvic pain syndrome. J. Urol. 171, 284-288 (2004).
32. De Rose, A. F., Gallo, F., Giglio, M. & Carmignani, G. Role of mepartricin in category iii chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology 63, 13-16 (2004).
33. Nickel, J. C. et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J. Urol. 173, 1252-1255 (2005).
34. Capodice, J. L., Bemis, D. L., Buttyan, R., Kaplan, S. A. & Katz, A. E. Complementary and alternative medicine for chronic prostatitis/ chronic pelvic pain syndrome. Evid. Based Complement. Alternat. Med. 2, 495-501 (2005).
35. Wagenlehner, F. M. et al. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, doubleblind, placebo-controlled phase 3 study. Eur. Urol. 56, 544-551 (2009).
36. Shoskes, D. A. et al. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J. Urol. 179, 556-560 (2008).
37. Zermann, D. H., ishigooka, M., Doggweiler, R. & Schmidt, R. A. Neurourological insights into the etiology of genitourinary pain in men. J. Urol. 161, 903-908 (1999).
38. Anderson, R. U., Wise, D., Sawyer, T. & Chan, C. integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J. Urol. 174, 155-160 (2005).
39. Anderson, R. U., Wise, D., Sawyer, T. & Chan, C. A. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J. Urol. 176, 1534-1539 (2006).
40. Weiss, J. M. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J. Urol. 166, 2226-2231 (2001).
41. Anderson, R. U., Sawyer, T., Wise, D., Morey, A. & Nathanson, B. H. Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J. Urol. 182, 2753-2758 (2009).
42. FitzGerald, M. P. et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J. Urol. 182, 570-580 (2009).
43. Clemens, J. Q. et al. Biofeedback, pelvic floor reeducation, and bladder training for male chronic pelvic pain syndrome. Urology 56, 951-955 (2000).
44. Nadler, R. B. Bladder training biofeedback and pelvic floor myalgia. Urology 60, 42-44 (2002).
45. Cornel, E. B., van Haarst, E. P., Schaarsberg, R. W. & Geels, J. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type iii. Eur. Urol. 47, 607-611 (2005).
46. Leskinen, M. J., Kilponen, A., Lukkarinen, O. & Tammela, T. L. Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category iii prostatitis): a randomized, shamcontrolled study. Urology 60, 300-304 (2002).
47. Kastner, C., Hochreiter, W., Huidobro, C., Cabezas, J. & Miller, P. Cooled transurethral microwave thermotherapy for intractable chronic prostatitis--results of a pilot study after 1 year. Urology 64, 1149-1154 (2004).
48. Pontari, M. et al. A randomized placebocontrolled multicenter trial of pregabalin for the treatment of men with chronic prostatitis/ chronic pelvic pain syndrome [abstract 340]. J. Urol. 181, 123 (2009).
49. Bennett, M. I. & Simpson, K. H. Gabapentin in the treatment of neuropathic pain. Palliat. Med. 18, 5-11 (2004).
50. Rose, M. A. & Kam, P. C. Gabapentin: pharmacology and its use in pain management. Anaesthesia 57, 451-462 (2002).
51. Guay, D. R. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin? Am. J. Geriatr. Pharmacother. 3, 274-287 (2005).
52. Gajraj, N. M. Pregabalin: its pharmacology and use in pain management. Anesth. Analg. 105, 1805-1815 (2007).
53. Chiechio, S. et al. Pregabalin in the treatment of chronic pain: an overview. Clin. Drug Investig. 29, 203-213 (2009).
54. Chizh, B. A. et al. Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br. J. Anaesth. 98, 246-254 (2007).
55. Gottrup, H. et al. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 101, 1400-1408 (2004).
56. Dworkin, R. H. et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60, 1524-1534 (2003).
57. Pfizer prescription products. LYRICA® US physician prescribing information [online], http:// media.pfizer.com/files/products/uspi-lyrica.pdf (2010).
58. Pfizer prescription products. Neurontin® US physician prescribing information [online], http:// media.pfizer.com/files/products/uspi-neurontin. pdf (2010).
59. Lyseng-williamson, K. A. & Siddiqui, M. A. Pregabalin: a review of its use in fibromyalgia. Drugs 68, 2205-2223 (2008).
60. Micó, J. A., Ardid, D., Berrocoso, E. & Eschalier, A. Antidepressants and pain. Trends Pharmacol. Sci. 27, 348-354 (2006).
61. Yaron, I. et al. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 42, 2561-2568 (1999).
62. Sindrup, S. H., Otto, M., Finnerup, N. B. & Jensen, T. S. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol. 96, 399-409 (2005).
63. Song, J. H., Ham, S. S., Shin, Y. K. & Lee, C. S. Amitriptyline modulation of Na(+) channels in rat dorsal root ganglion neurons. Eur. J. Pharmacol. 401, 297-305 (2000).
64. Benbouzid, M. et al. Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol. Psychiatry 63, 633-636 (2008).
65. Jang, S. w. et al. Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem. Biol. 16, 644-656 (2009).
66. Verdu, B., Decosterd, i., Buclin, T., Stiefel, F. & Berney, A. Antidepressants for the treatment of chronic pain. Drugs 68, 2611-2632 (2008).
67. Sator-Katzenschlager, S. M. et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien. Klin. Wochenschr. 117, 761-768 (2005).
68. Morello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F. & Sahagian, G. A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med. 159, 1931-1937 (1999).
69. Hanno, P. A new look at the use of amitriptyline for the treatment of interstitial cystitis: results of an NiH clinical trial. Presented at the 2009 Annual Meeting of the American Urological Association.
70. Kavirajan, H. Memantine: a comprehensive review of safety and efficacy. Expert Opin. Drug Saf. 8, 89-109 (2009).
71. Chen, H. S. & Lipton, S. A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97, 1611-1626 (2006).
72. Lipton, S. A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1, 101-110 (2004).
73. Parsons, C. G. NMDA receptors as targets for drug action in neuropathic pain. Eur. J. Pharmacol. 429, 71-78 (2001).
74. Mao, J., Price, D. D., Hayes, R. L., Lu, J. & Mayer, D. J. Differential roles of NMDA and non- NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 598, 271-278 (1992).
75. Mao, J., Price, D. D., Phillips, L. L., Lu, J. & Mayer, D. J. increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci. Lett. 198, 75-78 (1995).
76. Fischer, B. D., Carrigan, K. A. & Dykstra, L. A. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J. Pain 6, 425-433 (2005).
77. Dimitrakov, J. D., Chitalov, J. & Dechev, I. Memantine in the alleviation of symptoms of chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled trial [abstract 339]. J. Urol. 181, 123 (2009).
78. van Marum, R. J. Update on the use of memantine in Alzheimer's disease. Neuropsychiatr. Dis. Treat. 5, 237-247 (2009).
79. Nickel, J. C. Opioids for chronic prostatitis and interstitial cystitis: lessons learned from the 11th world Congress on Pain. Urology 68, 697-701 (2006).
80. Eisenberg, E., McNicol, E. D. & Carr, D. B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 293, 3043-3052 (2005).
81. Eisenberg, E., McNicol, E. D. & Carr, D. B. Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur. J. Pain 10, 667-676 (2006).
82. Mizoguchi, H., Watanabe, C., Yonezawa, A. & Sakurada, S. New therapy for neuropathic pain. Int. Rev. Neurobiol. 85, 249-260 (2009).
83. Miller, L. J. et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 59, 603-608 (2002).
84. Rudick, C. N., Schaeffer, A. J. & Thumbikat, P. Experimental autoimmune prostatitis induces chronic pelvic pain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1268-R1275 (2008).
85. Chuang, Y. C. et al. intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J. Urol. 180, 742-748 (2008).
86. Desireddi, N. V. et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J. Urol. 179, 1857-1862 (2008).
87. Penna, G. et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur. Urol. 51, 524-533 (2007).
88. Dimitrakov, J. D. A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology 58, 281 (2001).
89. Dimitrakov, J. & Guthrie, D. Genetics and phenotyping of urological chronic pelvic pain syndrome. J. Urol. 181, 1550-1557 (2009).
90. Pontari, M. A. Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: are they related? Curr. Urol. Rep. 7, 329-334 (2006).
91. Dimitrakov, J. et al. Adrenocortical hormone abnormalities in men with chronic prostatitis/ chronic pelvic pain syndrome. Urology 71, 261-266 (2008).
92. Siddall, P. J. et al. Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report. Anesth. Analg. 102, 1164-1168 (2006).